Methods for studying private sector supply of public health products in developing countries: a conceptual framework and review
Introduction
Recent years have seen increased recognition of the importance of the private sector in the health systems of low- and middle-income countries (Bennett, McPake, & Mills, 1997; Hanson & Berman, 1998; IHSD & LSHTM, 2000; Smith, Brugha, & Zwi, 2001). Private providers are an important source of care for poor people, who in many countries use the private sector nearly as much as better-off groups (Castro-Leal, Dayton, Demery, & Mehra, 2000).
A deepening understanding of the complexity of the private sector has contributed some description of the range of different providers involved (formal and informal, for-profit and non-profit, ranging from simple shops and solo practitioners through to complex organisations providing tertiary-level inpatient care). There is also growing evidence of the extent to which use of the private sector is segmented by socioeconomic status, suggesting that poor people are more likely to use the more informal parts of the private sector, such as shopkeepers, drug sellers, and solo practitioners who may not be formally qualified (Smith et al., 2001).
The range of types of health care which is purchased through the private sector is highly heterogeneous. The spectrum runs from complex services which include diagnostics and inpatient care, through to the supply of individual public health products (PHPs), such as condoms, mosquito nets, and certain over-the-counter drugs. While there is a growing evidence base concerning health services that are provided by the private sector, the information concerning the supply of commodities such as drugs and contraceptives is scanty, tends to fall outside of the general health services literature, and is often not considered in policy debates about the role of the private sector. We refer to such commodities as PHPs and define them in the next section.
Three arguments provide support for placing a higher priority on understanding the role of the private sector in distributing PHPs. First, private providers are an important and rapidly growing source of a variety of PHPs. Distribution data from the Philippines, for example, show that over the period 1994–2001, the private sector (including social marketing) share of the supply of oral contraceptives (OCs) increased from 26% to 43% of all cycles distributed (PSI, unpublished data). The volume of OCs provided by the private sector in Pakistan doubled over the period 1994–2000 (PSI, unpublished data). In Kenya, Demographic and Health Surveys (DHS) in 1989, 1993 and 1998 show a steady decline in the public share of condom supply (from 55% to 21%) and an increase in the share supplied by ‘other private’ sources (distinguished from ‘private medical’) from 25% to 52% (Measure DHS, 2002). In Indonesia, the government has completely phased out its supply of condoms, and the private sector share of distribution has risen from 50% in 1995 to 100% in 2001 (Purdy, 2002). The number of mosquito nets produced by manufacturers in Tanzania is estimated to have increased from 400,000 in 1994 to 1.2 million in 2000, with approximately half of these distributed through the private retail sector (Hanson & Jones, 2000).
A second justification for studying private supply of PHPs is that these products are often directed at problems of public health importance (e.g., sexually transmitted infections (STIs), malaria). And third, the provision of such essential health products through the private sector may create important new opportunities for expanding their use among target populations, most particularly among poor people. At the same time, there is a range of potential problems with private sector supply of PHPs that needs to be addressed, such as issues of affordability, accessibility and quality—issues around which there is currently relatively little information. Better information is needed about both the opportunities and potential problems of private sector supply of PHPs, in order to balance their effects, and to determine whether the appropriate policy response is to encourage private sector provision, tolerate it, or discourage it.
Typically, routine health information systems have very poor coverage of the private sector. Such information can often prove difficult to collect, as providers may be unwilling to provide details about their activities, or may lack paper records. In the face of this need for better information, the aim of this paper is to review the alternative methods for studying private sector supply of PHPs. While there have been a number of reviews of methods for studying specific products such as drugs (Ross, 1997; Van der Geest, 1982) or OCs (Green, 1988; Janowitz, Suazo, Fried, Bratt, & Bailey, 1992), this paper differs from existing reviews in two respects. First, it takes a broader perspective and focuses on the whole category of PHPs; and second, it focuses specifically on methods appropriate for studying the supply of these products in the private sector. We begin by proposing working definitions for the terms PHP and private providers. We go on to present a conceptual framework for understanding why markets for PHPs emerge, the public health implications of market provision of PHPs, and identify the variables which are of interest when studying the sales of PHPs through the private sector. We then review the main methods for studying PHP sales through the private sector, and some of the cross-cutting methodological issues such as constructing a sampling frame, the effects of seasonality and studying illicit behaviour. Finally, the discussion and conclusions are presented.
Section snippets
Public health products
We define PHPs as commodities that are used for treatment of diseases of public health importance or for the promotion of health, which can be provided at the retail level without a ‘service’ attached to them. Public health importance can be defined in a number of ways: the disease may be responsible for a large disease burden (e.g., malaria), or it may be associated with negative externalities (e.g., communicable diseases such as STIs). Examples of PHPs include condoms for prevention of STIs;
Understanding the public health implications of PHP sales: a conceptual framework
The central aim of studying private sales of PHPs is to identify both the problems and opportunities they pose, and to suggest potential areas and mechanisms for intervention through public policies. While private providers are known to be an important source of products used to address a range of public health priorities, there are many concerns about the quality and affordability of such products. Furthermore, there is likely to be considerable scope for expanding access to PHPs by making
Review of methods for studying the sales of PHPs
In this section we review the different field research methods used to trace the supply of health care products in the private sector. The information collected demonstrates the wide range of approaches available to a researcher, and the complementary way in which more than one method can be used.
Studies have been identified from the published and grey literatures. The INRUD, Medline and Popline databases were searched. Keywords included ‘retail’, ‘stores and storekeepers’, ‘private providers’,
Sampling frame and seasonality
A key difficulty with studying sellers of PHPs is constructing a sampling frame. A sampling frame should ideally list all the population members of the target population with each entry recorded only once. Commonly used sampling frames in developed countries are based on provider registration data or income tax records. However, in countries where these databases are not available, a specific sampling frame has to be constructed for the study.
Selecting a random sample of sellers to study is
Discussion and conclusions
Having acknowledged that the private sector is an important supplier of PHPs in developing countries, it follows that there is a need to understand and measure the actions and transactions that take place across this market. The conceptual framework presented in this paper suggests a means of understanding the public health implications of private sales of PHPs. All of the ten different methodologies listed above offer a means of tracing the sale and use of PHPs. However, the most appropriate
Acknowledgements
The framework presented here for conceptualising markets for public health commodities draws on collaborative work with Catherine Goodman and Anne Mills. We are grateful for helpful suggestions received from anonymous reviewers, and to Brian Smith, Elizabeth Warnick and Steven Chapman of PSI for providing unpublished project data on private sector supply of PHPs. The Health Economics and Financing Programme is funded by the UK Department for International Development. DFID supports policies,
References (62)
- et al.
Pharmacy dispensing practices for Sudanese children with diarrhoea
Public Health
(1989) - et al.
The relationship between mosquito density and mosquito coil sales in Dar es Salaam
Transactions of the Royal Society of Tropical Medicine & Hygiene
(1996) - et al.
Indications and warnings about chloramphenicol
The Lancet
(1973) Drug prescription and self-medication in IndiaAn explanatory survey
Social Science & Medicine
(1987)Pharmaceuticals in two Brazilian villagesLay practices and prescriptions
Social Science & Medicine
(1988)The use of modern pharmaceuticals in a Filipino villageDoctors’ prescription and self medication
Social Science & Medicine
(1987)Reported and actual prescription of oral rehydration therapy for childhood diarrhoeas by retail pharmacists in Nigeria
Social Science & Medicine
(1994)- et al.
Can licensed drug sellers contribute to safe motherhood? A survey of the treatment of pregnancy-related anaemia in Nepal
Social Science & Medicine
(1996) - et al.
Utilisation of pharmacies and pharmaceutical drugs in Addis Ababa, Ethiopia
Social Science & Medicine
(1986) - et al.
Purchase of antibiotics without prescription in Manila, The Philippines. inappropriate choices and doses
Journal of Clinical Epidemiology
(1990)
Undercover careseekersSimulated clients in the study of health provider behaviour in developing countries
Social Science & Medicine
The efficiency of inefficiency. Medicine distribution in South Cameroon
Social Science & Medicine
Self-care and the informal sale of drugs in South Cameroon
Social Science & Medicine
Oral contraceptive marketing in Ibadan, Nigeria
Social Science & Medicine
Assessment of the quality of prenatal careThe transmission of information to pregnant women in maternal and child health centres in Jordan
International Quarterly of Community Health Education
Dispensing drugs without prescription and treating patients by pharmacy attendants in Shiraz, Iran
American Journal of Public Health
The role of pharmacy shops in the management of acute uncomplicated childhood diarrhoea in Ghana
Ghana Medical Journal
Consumers of oral contraceptives in a social marketing program in Honduras
Studies in Family Planning
Private health providers in developing countries—serving the public interest?
Organization of ambulatory care provisionA critical determinant of health system performance in developing countries
WHO Bulletin
Monitoring tools for social marketing projectsThe distribution survey
Research methods in health
Public spending on health care in AfricaDo the poor benefit?
WHO Bulletin
Illicit sale of pharmaceuticals in AfricaSellers and clients in the suburbs of Dakar
Tropical & Geographical Medicine
Conducting focus group sessions
Studies in Family Planning
A consumer intercept study of oral contraceptive users in the Dominican Republic
Studies in Family Planning
Cited by (26)
Prohibit, constrain, encourage, or purchase: how should we engage with the private health-care sector?
2016, The LancetCitation Excerpt :Other debates have continued about the relative cost-effectiveness and equity effect of social marketing in comparison with alternative commodity delivery strategies such as free public provision and community health worker services.32,50 Social marketing focuses on public health commodities that can generally be delivered to end-users with little or no accompanying service by a health-care professional.51 By contrast, social franchising has been used for enhancing delivery of more complex services, provided principally in clinics or small hospitals.
The sexual and reproductive health care market in Bangladesh: Where do poor women go?
2011, Reproductive Health MattersKnowledge, legitimacy and economic practice in informal markets for medicine: A critical review of research
2010, Social Science and MedicineCitation Excerpt :But who are the informal providers of medicinal services and products in Africa and Asia and what do they do? In a growing and heterogeneous literature on the subject informal providers are said to vary considerably in terms of their formal qualifications and institutionalised training; their commercial orientation or dependence on medicine as a livelihood option; the complexity or scale of their organisation; and their position in a broader supply chain of health commodities (Conteh & Hanson, 2003). One approach to uncertainty over a precise definition of informal providers would be to narrow down their characteristics, to better delineate or fix them as a discrete category.
The economics of social marketing: The case of mosquito nets in Tanzania
2005, Social Science and MedicineImproving Accountability for Equitable Health and Well-being in Urban Informal Spaces: Moving from Dominant to Transformative Approaches
2024, Progress in Development Studies